Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, Colorado, USA.
J Med Food. 2024 Sep;27(9):814-823. doi: 10.1089/jmf.2023.0277. Epub 2024 Mar 12.
In the context of diabetes, the use of cinnamon continues to be among the most popular supplements taken by patients for glucose control. To strategically evaluate the available literature comparing various cinnamon species and statistically significant glucose effects after ranking studies based on two tools to assess bias and overall study quality, to clarify cinnamon's role in glucose control. The authors performed a systematic search based upon PRISMA guidelines. The search was conducted utilizing PubMed, AMED, CINAHL, EMBASE, Cochrane, and Medline databases, with the final search performed in September 2022 with restrictions to human subjects and English language. Electronic searches were conducted utilizing the keywords "diabetes mellitus" combined with // combined with blood glucose (BG). A second search utilized "cinnamomum zeylanicum/cinnamomum cassia/cinnamomum verum" combined with "blood glucose," and a final search utilized "diabetes mellitus" combined with "cinnamon." Data extraction and ranking of included studies utilizing the risk of bias 2 tool and modified Heyland Methodological Quality Scoring tool were performed independently by two review authors. These authors compared their results and reconciled any differences in scoring to generate a final ranking of studies. A third author was available for any discrepancies that could not be resolved but was not needed. Forty-five studies were included in the review and were scored for bias and quality. Overall 62% demonstrated statistical significance for positive effects in at least one parameter around BG control. Applying the ranking systems reduced the percentage closer to 50%. Safety was extremely well documented across studies with few adverse effects. Results are limited by heterogeneity of glucose parameters, leading to studies being ranked individually and not synthesized. Cinnamon supplementation likely has a modest positive effect on BG. Based upon the strong safety profile, utilization of this spice as an adjunct to pharmacologic therapy is reasonable.
在糖尿病领域,肉桂作为一种控制血糖的补充剂,是患者最常使用的草药之一。为了战略性地评估现有文献,比较不同肉桂品种,并根据两种评估偏倚和总体研究质量的工具对研究进行排名,以明确肉桂在血糖控制中的作用。作者根据 PRISMA 指南进行了系统搜索。该搜索在 PubMed、AMED、CINAHL、EMBASE、Cochrane 和 Medline 数据库中进行,最后一次搜索于 2022 年 9 月进行,限制为人类受试者和英语语言。电子搜索使用了“糖尿病”与“血糖(BG)”相结合的关键词。第二次搜索使用了“肉桂”与“血糖”相结合的“肉桂属 zeylanicum/cassia/cinnamomum verum”,最后一次搜索使用了“糖尿病”与“肉桂”相结合的关键词。两位评论作者分别独立使用风险偏倚 2 工具和改良的 Heyland 方法学质量评分工具提取和排名纳入研究的数据。这两位作者比较了他们的结果,并解决了评分上的任何差异,以生成研究的最终排名。任何无法解决的分歧都可以向第三位作者寻求帮助,但实际上并不需要。有 45 项研究被纳入综述,并对其偏倚和质量进行了评分。总体而言,62%的研究在至少一个血糖控制参数上显示出统计学意义的积极效果。应用排名系统后,这一比例接近 50%。安全性在研究中得到了很好的记录,只有少数不良反应。结果受到血糖参数异质性的限制,导致研究被单独评分而无法综合分析。肉桂补充剂可能对血糖有适度的积极影响。基于其良好的安全性,将这种香料作为药物治疗的辅助手段是合理的。